Launch of the Critical Path to TB Drug Regimens’ Advisory Panel
Share this
Related Posts
-
Critical Path Institute and TGen Forge Partnership to Advance TB Research -
ReSeqTB Data Platform Now Available to Public -
TB-ReFLECT: A Collaborative Effort to Enhance TB Clinical Research -
C-Path Selected as Host For New TB Clinical Trial Data-Sharing Platform -
European Medicines Agency Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug Development